Innovation Medical Management Co., Ltd. (002173.SZ)
CNY 12.41
(10.02%)
CNY 12.41
(10.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 11.03 Million | -24.44 Million | 43.37 Million | 131.66 Million | 96.36 Million | 129.43 Million |
| Net Income | -34.28 Million | -73.86 Million | -105.11 Million | -314.4 Million | -1.14 Billion | 29.94 Million |
| Depreciation & Amortization | 106.65 Million | 110.26 Million | 117.52 Million | 111.83 Million | 104.44 Million | 94.68 Million |
| Deferred income taxes | -3.15 Million | -1.41 Million | -3.91 Million | 21.39 Million | -18.01 Million | -7.79 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -43.01 Million | 9.81 Million | 18.91 Million | 137.96 Million | 76.16 Million | -140.5 Million |
| Other non-cash items | -18.32 Million | -70.65 Million | 12.04 Million | 196.26 Million | 1.06 Billion | 145.31 Million |
| Investing Cash Flow | -415.34 Million | 460.01 Million | -52.38 Million | -601.28 Million | 524.61 Million | -120.52 Million |
| Investments in PPE | -96.23 Million | -123.17 Million | -110.72 Million | -108.35 Million | -160.46 Million | -399.86 Million |
| Acquisitions | 343.62 Thousand | 167.02 Thousand | 35.62 Million | 34.32 Million | 80 Million | 120.58 Million |
| Investment purchases | -319.99 Million | -30 Million | -695 Million | -1.27 Billion | -510 Million | -1.71 Billion |
| Sales/Maturities of investments | -343.62 Thousand | 612.73 Million | 710.51 Million | 742.74 Million | 1.11 Billion | 1.88 Billion |
| Other Investing Activities | 895.48 Thousand | 291.19 Thousand | 7.2 Million | 1 Million | -1.64 Million | -16.24 Million |
| Financing Cash Flow | -4.97 Million | -2.97 Million | -111.41 Million | -63.49 Million | -314.53 Million | 3.03 Million |
| Debt repayment | -23 Million | -12 Million | -33 Million | -29.22 Million | -366.7 Million | -325.71 Million |
| Dividends payments | -1.46 Million | -794.97 Thousand | -2.35 Million | -3.72 Million | -11.92 Million | -64.5 Million |
| Common Stock Repurchased | -2.00 | - | -48.4 Million | - | - | - |
| Common Stock Issuance | - | - | 48.4 Million | - | - | - |
| Other Financing Activities | -10.51 Million | 9.82 Million | -76.05 Million | -30.54 Million | 64.09 Million | 393.25 Million |
| Accounts receivables | -49.06 Million | 35.99 Million | 11.69 Million | 59.96 Million | 61.32 Million | -48.33 Million |
| Accounts payables | 2.38 Million | -18.06 Million | 19.14 Million | 39.38 Million | 37.63 Million | -84.74 Million |
| Inventory | 6.82 Million | -6.7 Million | -8 Million | 17.22 Million | -4.77 Million | 373.99 Thousand |
| Other working capital | -3.15 Million | -1.41 Million | -3.91 Million | 21.39 Million | -18.01 Million | -140.87 Million |
| Cash at beginning of period | 658.3 Million | 225.71 Million | 346.14 Million | 879.25 Million | 572.79 Million | 560.82 Million |
| Cash at end of period | 249.01 Million | 658.3 Million | 225.71 Million | 346.14 Million | 879.25 Million | 572.79 Million |
| Capital Expenditure | -96.23 Million | -123.17 Million | -110.72 Million | -108.35 Million | -160.46 Million | -399.86 Million |
| Effect of forex changes on cash | 0.94 | 0.19 | 0.70 | - | -0.23 | 18.77 Thousand |
| Net cash flow / Change in cash | -409.28 Million | 432.59 Million | -120.43 Million | -533.11 Million | 306.45 Million | 11.97 Million |
| Free Cash Flow | -85.2 Million | -147.62 Million | -67.35 Million | 23.3 Million | -64.09 Million | -270.43 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.81 Million | -13.05 Million | -2.97 Million | -34.28 Million | -20.07 Million | -10.76 Million |
| Depreciation & Amortization | - | 27.15 Million | 27.15 Million | 106.65 Million | 29.09 Million | -49.87 Million |
| Deferred income taxes | - | - | - | -3.15 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -7.18 Million | - | -43.01 Million | -79.94 Million | 11.72 Million |
| Other non-cash items | 30.83 Million | 54.09 Million | -14.68 Million | -18.32 Million | 53.43 Million | 60.76 Million |
| Investing Cash Flow | -40.86 Million | -352.49 Million | 288.14 Million | -415.34 Million | -348.75 Million | -22.84 Million |
| Investments in PPE | -23.79 Million | -16.72 Million | -16.41 Million | -96.23 Million | -29.23 Million | -22.91 Million |
| Acquisitions | 274.01 Thousand | 74.51 Thousand | - | 343.62 Thousand | -71.35 Thousand | 72.97 Thousand |
| Investment purchases | -117.57 Million | -343.88 Million | -397.9 Thousand | -319.99 Million | -319.99 Million | - |
| Sales/Maturities of investments | 100.23 Million | 8.04 Million | 304.95 Million | -343.62 Thousand | 320.06 Million | - |
| Other Investing Activities | 274.01 Thousand | 74.51 Thousand | 304.56 Million | 895.48 Thousand | -319.51 Million | 0.29 |
| Financing Cash Flow | -7.09 Million | 4.63 Million | 10.45 Million | -4.97 Million | -5.62 Million | 28.73 Million |
| Debt repayment | -2 Million | -8.87 Million | -13 Million | -23 Million | - | -30 Million |
| Dividends payments | -728.03 Thousand | -513.68 Thousand | -599.83 Thousand | -1.46 Million | -312.47 Thousand | -318.46 Thousand |
| Common Stock Repurchased | - | - | - | -2.00 | -2.00 | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -4.36 Million | 929.39 Thousand | -1.94 Million | -10.51 Million | -5.31 Million | 59.05 Million |
| Accounts receivables | - | 3.23 Million | - | -49.06 Million | -49.06 Million | 22.89 Million |
| Accounts payables | - | - | - | 2.38 Million | - | -25.3 Million |
| Inventory | - | 5.62 Million | - | 6.82 Million | 6.82 Million | -11.17 Million |
| Other working capital | - | -16.04 Million | - | -3.15 Million | -37.7 Million | 25.3 Million |
| Cash at beginning of period | 195.98 Million | 543.82 Million | 249.01 Million | 658.3 Million | 620.88 Million | 603.13 Million |
| Cash at end of period | 167.04 Million | 555.53 Million | 529.95 Million | 249.01 Million | 249.01 Million | 620.88 Million |
| Capital Expenditure | -23.79 Million | -16.72 Million | -16.41 Million | -96.23 Million | -29.23 Million | -22.91 Million |
| Effect of forex changes on cash | - | - | - | 0.94 | -0.60 | 1.07 |
| Net cash flow / Change in cash | -28.93 Million | 11.71 Million | 280.93 Million | -409.28 Million | -371.86 Million | 17.74 Million |
| Free Cash Flow | -4.77 Million | -2.83 Million | -34.08 Million | -85.2 Million | -46.72 Million | -11.05 Million |
GJST
SFIN
TWR
JUBILE
TKUN
OPESF